Alkermes is focused on developing innovative medicines that aim to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated global biopharmaceutical company, we apply our scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference in the way people manage their diseases.
Beyond our central mission to develop medicines, we believe in championing approaches to treatment that account for the multitude of factors that affect outcomes for patients, caregivers and communities. In addition to our scientific pursuits, we are committed to patient engagement, disease education and awareness and advocacy for important policies that support equitable access to treatment options.
We believe that being a positive force for change begins when we dare to expect more – of medicines, of our healthcare system and of ourselves – as we seek to reset expectations of what constitutes successful management of complex diseases.
U.S. Corporate Offices and R&D
Manufacturing and R&D